Related Experiment Video
Updated: Aug 7, 2026

07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
Adrenal insufficiency in T-cell lymphoma
Wen-Chiuan Tsai1, Cheng-Da Hsieh, Ming-Fang Cheng
1Department of Pathology, Tri-Service General Hospital, Taipei, Taiwan.
Summary
Primary adrenal lymphoma (PAL) is a rare T-cell cancer. Combination therapy may improve outcomes for PAL, but more research is needed due to limited patient data.
Area of Science:
- Oncology
- Hematology
- Endocrinology
Background:
- Primary adrenal lymphoma (PAL) is an exceptionally rare T-cell neoplasm.
- Adrenal insufficiency can be a presenting symptom of PAL.
Observation:
- A 42-year-old woman presented with constitutional symptoms including fevers and night sweats.
- Diagnosis was confirmed as primary adrenal T-cell lymphoma (PATL) with associated adrenal insufficiency.
Findings:
- The patient expired two months post-chemotherapy and prednisolone treatment.
- Literature review suggests poor survival rates with single therapeutic modalities for PAL.
- One reported case of adrenectomy followed by radiotherapy achieved long-term survival.
Implications:
- Combined therapeutic modalities might offer a better prognosis for PATL patients.
- Further research with larger patient cohorts is necessary to establish optimal treatment strategies.
- Early diagnosis and multimodal treatment approaches are crucial for managing this rare condition.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
